Prospective Collection of Tumor Biopsy and Plasma Samples From Cancer Patients Treated With Molecular Targeted Therapies or Immunotherapy

NCT03835520 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: Immunotherapeutic Agent
DRUG: Molecular Target

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain